Marc A.
- Country
- Belgium
- Department
- Médecine interne
Research Overview
- Evaluation of Long-Term Safety and Efficacy of Litifilimab in Adults with Active Systemic Lupus Erythematosus: A Phase 3 Multicenter, Randomized, Dose-Blind Study
- Efficacy and Safety Evaluation of Litifilimab in Adults with Active Systemic Lupus Erythematosus on Nonbiologic Standard of Care: A Phase 3 Randomized Controlled Trial
- Comparative Efficacy and Safety of Adalimumab Versus Mycophenolate Mofetil in Steroid-Dependent Non-Infectious Uveitis
Data & Insights
Has run more than one trial at 74 of 156 partner sites.
Specializations
Autoimmune Disorders
Specializes in treating complex systemic lupus erythematosus, with particular focus on interferon signature modulation and innovative therapeutic approaches.
- Lupus Management Strategies
- Disease Activity Assessment
- Novel Biologic Therapies
Inflammatory Eye Conditions
Expert in treating non-infectious uveitis and Behçet's disease related eye complications, utilizing advanced biological treatments and monitoring strategies.
- Uveitis Treatment Optimization
- Therapeutic Drug Monitoring
- Biological Response Assessment
Systemic Vasculitis
Focuses on treating giant cell arteritis, IgA vasculitis, and granulomatosis with polyangiitis, implementing targeted immunological interventions.
- Vasculitis Management
- Immunotherapy Approaches
- Treatment Resistance Solutions
Connective Tissue Disorders
Investigates innovative treatments for systemic sclerosis, focusing on skin fibrosis reduction and disease progression management.
- Fibrosis Treatment
- Disease Modification Strategies
- Long-term Outcome Assessment
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.